Trials / Completed
CompletedNCT03484065
Quality of Life in Patients With Congenital Afibrinogenemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (actual)
- Sponsor
- University Hospital, Geneva · Academic / Other
- Sex
- All
- Age
- 8 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this observational study is to evaluate the quality of life in patients with congenital afibrinogenemia using the Haemo-QoL SF for kids and the Haem-A-QoL for adult patients.
Detailed description
In this observational study, children and adults suffering from congenital afibrinogenemia confirmed by biology will be enrolled. All patients will receive a questionnaire on quality of life in their own language during a routine visit and filled out by the patient at home. A general questionnaire will be filled out by the patient's physician.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire quality of life |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2019-07-01
- Completion
- 2020-06-01
- First posted
- 2018-03-30
- Last updated
- 2020-11-12
Locations
28 sites across 21 countries: United States, Algeria, Canada, Egypt, France, Germany, India, Italy, Japan, Kuwait, Lebanon, Morocco, Netherlands, Pakistan, Poland, Serbia, Slovakia, Spain, Switzerland, Tunisia, Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03484065. Inclusion in this directory is not an endorsement.